Serum IL-2R as an indicator of residual disease in patients with malignant lymphomas
Journal of the Egyptian National Cancer Institute. 1996; 8 (1): 97-106
in En
| IMEMR
| ID: emr-41528
Responsible library:
EMRO
Subject(s)
Search on Google
Index:
IMEMR
Main subject:
Receptors, Interleukin-2
/
CD4-CD8 Ratio
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
J. Egypt. Natl. Cancer Inst.
Year:
1996